Kangstem Biotech Co. Ltd (217730) — Working Capital to Net Assets Ratio
Kangstem Biotech Co. Ltd (217730) has a Working Capital to Net Assets ratio of 46.2% as of March 2026. Working capital of ₩28.73 Billion (current assets of ₩36.81 Billion minus current liabilities of ₩8.08 Billion) is measured against net assets of ₩62.25 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Kangstem Biotech Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kangstem Biotech Co. Ltd Working Capital to Net Assets (2015–2025)
This chart shows how Kangstem Biotech Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 46.2%, reflecting working capital of ₩28.73 Billion against net assets of ₩62.25 Billion KRW. See 217730 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Kangstem Biotech Co. Ltd (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kangstem Biotech Co. Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 217730 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.2% | ₩35.33 Billion | ₩69.06 Billion | ₩43.63 Billion | ₩8.30 Billion | ▲ +3.0 pp |
| 2024 | 48.2% | ₩20.80 Billion | ₩43.18 Billion | ₩28.53 Billion | ₩7.73 Billion | ▼ -3.9 pp |
| 2023 | 52.0% | ₩23.17 Billion | ₩44.52 Billion | ₩47.37 Billion | ₩24.20 Billion | ▼ -14.9 pp |
| 2022 | 66.9% | ₩31.64 Billion | ₩47.26 Billion | ₩45.91 Billion | ₩14.27 Billion | ▼ -3.8 pp |
| 2021 | 70.8% | ₩48.16 Billion | ₩68.07 Billion | ₩65.36 Billion | ₩17.19 Billion | ▲ +7.7 pp |
| 2020 | 63.0% | ₩32.54 Billion | ₩51.62 Billion | ₩44.75 Billion | ₩12.21 Billion | ▲ +13.8 pp |
| 2019 | 49.2% | ₩34.81 Billion | ₩70.72 Billion | ₩55.41 Billion | ₩20.60 Billion | ▼ -11.5 pp |
| 2018 | 60.7% | ₩28.94 Billion | ₩47.69 Billion | ₩48.99 Billion | ₩20.06 Billion | ▼ -19.7 pp |
| 2017 | 80.4% | ₩18.88 Billion | ₩23.47 Billion | ₩25.25 Billion | ₩6.37 Billion | ▼ -70.8 pp |
| 2016 | 151.2% | ₩34.74 Billion | ₩22.98 Billion | ₩37.97 Billion | ₩3.23 Billion | ▲ +76.2 pp |
| 2015 | 75.0% | ₩15.93 Billion | ₩21.24 Billion | ₩18.90 Billion | ₩2.97 Billion | — |